Xconomy Boston

Rib-X Pharmaceuticals Inc. Lands $25,000,000 Series D Round

  • Feed Type
  • Date
    2/4/2009
  • Company Name
    Rib-X Pharmaceuticals Inc.
  • Mailing Address
    300 George Street New Haven, CT 06511-6663
  • Company Description
    Rib-X Pharmaceuticals is a product-driven small molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. The company’s underlying drug discovery engine capitalizes on its proprietary high-resolution crystal structure of the 50S subunit of the ribosome, which performs an essential role in the fundamental process of protein synthesis.
  • Website
    http://www.rib-x.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $25,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Warburg Pincus
  • Venture Investor
    ABS Ventures
  • Venture Investor
    Axiom Venture Partners
  • Venture Investor
    EuclidSR Partners
  • Venture Investor
    MedImmune Ventures
  • Venture Investor
    Oxford Bioscience Partners
  • Venture Investor
    SR One
  • Venture Investor
    Undisclosed

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.